These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29970037)

  • 1. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.
    Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y
    BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
    Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
    BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of drug-induced liver injury in chronic hepatitis B and tuberculosis co-infection: A systematic review and meta-analysis.
    Chou C; Veracruz N; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 Dec; 29(12):1107-1114. PubMed ID: 36138556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult hepatitis B virus infection: clinical implications in tuberculosis treatment.
    Trigo C; do Brasil PE; Costa MJ; de Castro L
    J Viral Hepat; 2016 Dec; 23(12):1027-1035. PubMed ID: 27624908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
    World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies.
    Zheng J; Guo MH; Peng HW; Cai XL; Wu YL; Peng XE
    Epidemiol Infect; 2020 Nov; 148():e290. PubMed ID: 33222713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and outcomes of drug-induced liver injury in Taiwan: With emphasis on the impact of chronic hepatitis B infection.
    Huang YS; Tseng SY; Chen WW; Chang TT; Peng CY; Lo GH; Hsu CW; Hu CT; Huang YH
    J Chin Med Assoc; 2022 Mar; 85(3):286-294. PubMed ID: 34698694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of chronic viral hepatitis on tuberculosis treatment interruption.
    Chua AP; Lim LK; Gan SH; Chee CB; Wang YT
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1486-1494. PubMed ID: 30606322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus.
    Pan L; Jia ZS; Chen L; Fu EQ; Li GY
    World J Gastroenterol; 2005 Apr; 11(16):2518-21. PubMed ID: 15832429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosis.
    Zhu CH; Zhao MZ; Chen G; Qi JY; Song JX; Ning Q; Xu D
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):105-109. PubMed ID: 28224437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
    Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
    J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with tuberculous meningitis and hepatitis B co-infection have increased risk for antituberculosis drug-induced liver injury and poor outcomes.
    Mo X; Xu X; Ren Z; Guan J; Peng J
    Infect Dis (Lond); 2020 Nov; 52(11):793-800. PubMed ID: 32619380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury.
    Naidoo S; Evans D; Jong E; Mellet K; Berhanu R
    S Afr Med J; 2015 Apr; 105(5):393-6. PubMed ID: 26242667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of chronic HBV infection on superimposed acute hepatitis E.
    Cheng SH; Mai L; Zhu FQ; Pan XF; Sun HX; Cao H; Shu X; Ke WM; Li G; Xu QH
    World J Gastroenterol; 2013 Sep; 19(35):5904-9. PubMed ID: 24124337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.
    Lomtadze N; Kupreishvili L; Salakaia A; Vashakidze S; Sharvadze L; Kempker RR; Magee MJ; del Rio C; Blumberg HM
    PLoS One; 2013; 8(12):e83892. PubMed ID: 24367617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
    Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
    Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection.
    Wong WM; Wu PC; Yuen MF; Cheng CC; Yew WW; Wong PC; Tam CM; Leung CC; Lai CL
    Hepatology; 2000 Jan; 31(1):201-6. PubMed ID: 10613746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States.
    Wong RJ; Rupp L; Lu M; Yang Z; Daida YG; Schmidt M; Boscarino JA; Gordon SC; Chitnis AS
    J Viral Hepat; 2023 Jun; 30(6):512-519. PubMed ID: 36843435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: Systematic review and meta-analysis.
    Wang NT; Huang YS; Lin MH; Huang B; Perng CL; Lin HC
    J Chin Med Assoc; 2016 Jul; 79(7):368-74. PubMed ID: 27032895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antituberculous drug-induced liver injury: current perspective.
    Devarbhavi H
    Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.